Jacqueline A Pongracic, MD
Disclosures: Consulting Fee-Current-DBV Technologies|Contracted Research-Current-DBV Technologies|Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-Current-Westat|Contracted Research-Current-Aimmune Therapeutics|Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent-Current-DBV Technologies|Consulting Fee-Current-Regerneron - 09/10/2020
No Bio Available.